SENIOR TRI INVESTIGATORS AND ADMINISTRATORS
- Senior Staff (Pechura, Weinstein, Metzger)
- Section on Behavioral Interventions
- Section on Law & Ethics
- Section on Treatment Systems Research
- Center on the Continuum of Care: Monitoring and Adapting Addictions Treatment
- Center for Policy Research and Analysis
- Section on Adolescents
- Treatment Research Solutions Group
- Wharton-TRI Center on the Organization and Management of Addiction Treatment
- Clinical Trials Network
Ken
Winters, Ph.D.
is the director of the Center for Adolescent Substance Abuse Research,
a Professor in the Department of Psychiatry at the University of Minnesota,
and a Senior Scientist with the Treatment Research Institute, Philadelphia,
PA. He received his B.A. from the University of Minnesota and a Ph.D.
in psychology (Clinical) from the State University of New York at Stony
Brook. His primary research interests are the assessment and treatment
of adolescent drug abuse. Dr. Winters has published numerous research
articles in this area, and has received several research grants from the
National Institute of Health (NIH) and various foundations. He currently
directs grants funded by NIH to study the effectiveness of brief interventions
with drug abusing adolescents. He is on the editorial boards of the Journal
of Child and Adolescent Substance Abuse and the Journal of Substance
Abuse Treatment, and he was also the lead editor for two Treatment
Improvement Protocol Series published by the Center for Substance
Abuse Treatment (SAMHSA) that focused on adolescent drug abuse assessment
and treatment. Dr. Winters is a consultant to many organizations, including
the Hazelden Foundation, National Institute on Drug Abuse, Center for
Substance Abuse Treatment, the Partnership for Drug-Free America, World
Health Organization, and the Mentor Foundation (an international drug
abuse prevention organization).
Amelia
M. Arria, Ph.D., Senior Scientist, is an adolescent and young-adult
specialist at TRI and Principal Investigator on the College Life Study
at the School of Public Health, University of Maryland, College Park.
Her primary area of interest is the identification of risk factors for
adolescent and young adult drug involvement. She is also involved in research
evaluating the safety and efficacy of buprenorphine and methadone for
pregnant opioid-dependent women, prenatal methamphetamine exposure, and
characterizing faith-based elements of drug treatment.
Behavioral
Interventions
Law
& Ethics
Treatment
Systems Research
Center
on the Continuum of Care:
Monitoring
and Adapting Addiction Treatment
Center
for Policy Research and
Analysis
Adolescents
Treatment
Research Solutions
Wharton-TRI
Center on the
Organization
and Management of Addiction Treatment
Clinical
Trials Network
Addiction
Severity Index (ASI)
Other
Assessment Instruments
Publications
Presentations
Archives
Training
Order
TRI Resources
Contact
Us
Sign
up for E-Alerts